Trial intelligence / Profile preview

Na/K citrate for prevention of contrast media-induced acute kidney injury

IRCT2015011618389N3Phase 3Completed

Sponsor
Qom University of Medical Sciences
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of potassium citrate + sodium citrate hydrate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Qom University of Medical Sciences. Started Jan 2015; status: completed.

02

Drugs

potassium citrate + sodium citrate hydrate
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on IRCT2015011618389N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015011618389N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call